Cornell Vaginal Ring | The Contraceptive Pipeline Database

Product Overview

Alternative Name: BioRings Intravaginal Ring

Description: A vaginal ring that releases multiple types of non-hormonal agents and microbicides/anti-viral agents, including ferrous gluconate, ascorbic acid, pharmalytes, boclysinated betulonic acid, and tenofovir.

Updated date: May 30, 2018

Vertical Tabs

Product Details

Active Pharmaceutical Ingredient (API): , , ,

Inactive material: nanoporous elastomere hydrogel

Duration: 28 days

Partner: , ,

Status

Programmatic Considerations

Additional Information

Additional Information:
Biorings Company Website

2015 Press Release: Non-Hormonal Intra-Vaginal Ring Contraceptive to be Developed by QPharma AB and BioRings LLC

2009 Press Release: Cornell researchers develop anti-viral vaginal ring

Han YA, Singh M, Saxena BB. (2007) Development of vaginal rings for sustained release of nonhormonal contraceptives and anti-HIV agents. Contraception. 76(2):132-8.

Download Product Report